Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2008Assay and Drug Development Technologies

An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate Depletion

View Full Paper
Ask AI
Bookmark
Share

Authors

CMColleen A. McNaneyBristol-Myers Squibb (United States)DDDieter M. DrexlerBristol-Myers Squibb (Germany)SHSerhiy Hnatyshyn

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

McNaney et al. (2008) studied this question.

synapsesocial.com/papers/6a82b47f032e48224a10b925https://doi.org/10.1089/adt.2007.103
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of ADME Characteristics in Drug Discovery and Their In Silico Evaluation: In Silico Screening of Chemicals for their Metabolic Stability2003 · 81 citations
  2. 2The Simultaneous Determination of Mixtures of Drug Candidates by Liquid Chromatography/Atmospheric Pressure Chemical Ionization Mass Spectrometry as anIn Vivo Drug Screening Procedure1997 · 150 citations
  3. 3The Pharmaceutical Industry — Prices and Progress2004 · 130 citations
  4. 4High Throughput Liquid Chromatography-Mass Spectrometry Assessment of the Metabolic Activity of Commercially Available Hepatocytes from 96-Well Plates1999 · 17 citations